[
  {
    "ticker": "AGIO",
    "companyName": "Agios Pharmaceuticals",
    "drugName": "Vorasidenib",
    "indication": "IDH-mutant glioma (brain cancer)",
    "pdufa_date": "2024-12-07",
    "approvalType": "NDA",
    "notes": "PDUFA date passed - check for decision"
  },
  {
    "ticker": "CYTK",
    "companyName": "Cytokinetics",
    "drugName": "Aficamten",
    "indication": "Hypertrophic cardiomyopathy (HCM)",
    "pdufa_date": "2024-12-26",
    "approvalType": "NDA",
    "notes": "Highly anticipated cardiac drug"
  },
  {
    "ticker": "CORT",
    "companyName": "Corcept Therapeutics",
    "drugName": "Relacorilant",
    "indication": "Cushing's syndrome",
    "pdufa_date": "2024-12-30",
    "approvalType": "NDA",
    "notes": "Selective cortisol modulator"
  },
  {
    "ticker": "DNLI",
    "companyName": "Denali Therapeutics",
    "drugName": "DNL747",
    "indication": "Alzheimer's disease",
    "pdufa_date": "2025-01-05",
    "approvalType": "BLA",
    "notes": "Neurodegenerative disease treatment"
  },
  {
    "ticker": "TVTX",
    "companyName": "Travere Therapeutics",
    "drugName": "Sparsentan",
    "indication": "IgA nephropathy",
    "pdufa_date": "2025-01-10",
    "approvalType": "NDA",
    "notes": "Rare kidney disease"
  },
  {
    "ticker": "ARVN",
    "companyName": "Arvinas Inc",
    "drugName": "ARV-471",
    "indication": "Breast cancer (ER+/HER2-)",
    "pdufa_date": "2025-12-28",
    "approvalType": "NDA",
    "notes": "PROTAC protein degrader, highly innovative"
  },
  {
    "ticker": "MDGL",
    "companyName": "Madrigal Pharmaceuticals",
    "drugName": "Resmetirom",
    "indication": "NASH (non-alcoholic steatohepatitis)",
    "pdufa_date": "2026-01-15",
    "approvalType": "NDA",
    "notes": "First-in-class NASH treatment"
  },
  {
    "ticker": "IMVT",
    "companyName": "Immunovant",
    "drugName": "IMVT-1402",
    "indication": "Autoimmune diseases",
    "pdufa_date": "2026-01-22",
    "approvalType": "BLA",
    "notes": "FcRn antagonist platform"
  },
  {
    "ticker": "KROS",
    "companyName": "Keros Therapeutics",
    "drugName": "KER-050",
    "indication": "Pulmonary arterial hypertension",
    "pdufa_date": "2026-01-18",
    "approvalType": "NDA",
    "notes": "TGF-beta pathway modulator"
  },
  {
    "ticker": "RCKT",
    "companyName": "Rocket Pharmaceuticals",
    "drugName": "RP-L201",
    "indication": "Fanconi anemia",
    "pdufa_date": "2026-01-12",
    "approvalType": "BLA",
    "notes": "Gene therapy for rare disease"
  }
]
